innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively … than decreasing the expected returns to innovation, this aspect of regulation contributes to the value of new drugs and may … actually encourage innovation. This point has largely been absent from most cost-benefit analyses of drug regulation, yet …

This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category …